以用户驱动的妊娠期剂量选择框架:舍曲林概念验证
针对妊娠期多数药物缺乏循证产前剂量的问题,本研究开发并试点了一个用户驱动的妊娠期剂量选择框架,并以舍曲林为例制定产前给药策略。框架涵盖药物选择依据、药代动力学与剂量相关疗效安全性综合分析,以及基于结构化母婴获益-风险评估的实施可行性评估,最终舍曲林产前剂量推荐获多学科工作组认可用于临床。
要点
- 妊娠期生理变化可改变母婴药代动力学,但多数药物缺乏循证产前剂量。
- 用户驱动框架整合药代动力学、疗效安全性数据及母婴获益-风险评估。
- 舍曲林产前剂量推荐经多学科工作组评估后获认可用于临床。
核心结论
- 用户驱动的妊娠期剂量选择框架可用于制定舍曲林产前剂量推荐,并获多学科工作组认可用于临床。
研究设计与样本
- 研究开发并试点妊娠期剂量选择框架,经专家初步开发评估后,以舍曲林为例制定产前给药策略,再由多学科工作组评估可用性。
主要发现
- 框架涵盖药物选择依据、药代动力学与剂量相关疗效安全性综合分析,以及基于结构化母婴获益-风险评估的实施可行性评估。
临床怎么用
- 临床可参考该框架整合药代动力学与获益-风险评估,为妊娠期患者制定舍曲林产前剂量。
局限性
- 框架目前仅以舍曲林作为概念验证,未来需在其他药物中应用以进一步证明其适用性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite growing knowledge of pregnancy-induced changes in physiology that may alter maternal and fetal pharmacokinetics, evidence-based antenatal doses are lacking for most drugs. Pharmacokinetic modeling and expanding clinical data in pregnancy may support antenatal doses. We aimed to develop and pilot a comprehensive and user-driven Framework for Dose Selection in Pregnancy to support the clinical implementation of a best-evidence antenatal dose for sertraline. After initial development and evaluation by experts, the framework prototype was piloted to formulate an antenatal dosing strategy for sertraline in depression and anxiety disorders. Next, the framework was reviewed and assessed for usability by a multidisciplinary working committee of end-users comprising healthcare practitioners, experts from other disciplines including pharmacometrics, reproductive toxicology and medical ethics, alongside pregnant women and a partner. The resulting framework encompasses the following: rationale for drug selection, a comprehensive analysis of pharmacokinetic and dose-related efficacy and safety data, and implementation aspects including feasibility and desirability of the recommended antenatal dose based on a structured maternal and fetal benefit-risk assessment. An antenatal dose recommendation for sertraline, as a case study, was formulated using this approach and endorsed for clinical use by the working committee. Future applications of the framework for other drugs can further demonstrate its suitability for developing best evidence, acceptable and clinically feasible antenatal doses.
引用
- Koldeweij C, Dibbets C, Franklin BD, et al. A User-Driven Framework for Dose Selection in Pregnancy: Proof of Concept for Sertraline. Clin Pharmacol Ther. 2024. PMID: 39248386. doi:10.1002/cpt.3429
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。